Dose-response effects of spectrum research cigarettes

Nicotine and Tobacco Research

Volumn 15, Issue 6, 2013, Pages 1113-1121

  Hatsukami, Dorothy K ^a   Heishman, Stephen J ^b   Vogel, Rachel Isaksson ^c   Denlinger, Rachel L ^d   Roper Batker, Astia N ^a   Mackowick, Kristen M ^b   Jensen, Joni ^a   Murphy, Sharon E ^c   Thomas, Brian F ^e   Donny, Eric ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; COTININE; NICOTINE GUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRONCHITIS; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; EMPHYSEMA; FEMALE; HEALTH HAZARD; HEART DISEASE; HEART RATE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REWARD; SMOKING; SYSTOLIC BLOOD PRESSURE; TOBACCO DEPENDENCE; ADOLESCENT; ANALYSIS; BEHAVIOR; BLOOD PRESSURE; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIOR; BLOOD PRESSURE; COTININE; DEMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PILOT PROJECTS; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84877827552     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts247     Document Type: Article

References (17)

1. Benowitz, N. L., Dains, K. M., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., & Jacob, P., 3rd. (2012). Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiology, Biomarkers & Prevention, 21, 761-769. doi:10.1158/1055-9965.EPI-11-0644
2. Benowitz, N. L., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., & Jacob, P., 3rd. (2007). Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiology, Biomarkers & Prevention, 16, 2479-2485. doi:10.1158/1055-9965.EPI-07-0393
3. Benowitz, N. L., & Henningfield, J. E. (1994). Establishing a nicotine threshold for addiction. The implications for tobacco regulation. The New England Journal of Medicine, 331, 123-125.
4. Benowitz, N. L., Jacob, P., 3rd, & Herrera, B. (2006). Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clinical Pharmacology and Therapeutics, 80, 703-714. doi:10.1016/j.clpt.2006.09.007
5. Cappelleri, J. C., Bushmakin, A. G., Baker, C. L., Merikle, E., Olufade, A. O., & Gilbert, D. G. (2007). Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addictive Behavior, 32, 912-923. doi:10.1016/j.addbeh.2006.06.028
6. Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ, 328, 1519. doi:10.1136/bmj.38142.554479.AEbmj.38142.554479.AE[pii]
7. Gray, N., Henningfield, J. E., Benowitz, N. L., Connolly, G. N., Dresler, C., Fagerstrom, K.,. Boyle, P. (2005). Toward a comprehensive long term nicotine policy. Tobacco Control, 14, 161-165. doi:10.1136/tc.2004.010272
8. Hatsukami, D., Kotlyar, M., Hertsgaard, L. A., Zhang, Y., Carmella, S. G., Jensen, J. A.,. Hecht, S. S. (2010). Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction, 105, 343-355. doi:10.1111/j.1360-0443.2009.02780.x
9. Hatsukami, D., Perkins, K. A., Lesage, M. G., Ashley, D. L., Henningfield, J. E., Benowitz, N. L.,. Zeller, M. (2010). Nicotine reduction revisited: science and future directions. Tobacco Control, 19, e1-e10. doi:10.1136/tc.2009.035584
10. Jacobs, E. A., & Bickel, W. K. (1999). Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients. Experimental and Clinical Psychopharmacology, 7, 412-426.
11. Murphy, S. E., Link, C. A., Jensen, J., Le, C., Puumala, S. S., Hecht, S. S.,. Hatsukami, D. (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiology, Biomarkers and Prevention, 13, 1617-1623.
12. Peto, R., Lopez, A. D., Boreham, J., Thun, M., & Heath, C. Jr. (1992). Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet, 339, 1268-1278.
13. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D., & Riedel, K. (2007). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regulatory Toxicology and Pharmacology, 47, 171-183. doi:10.1016/j.yrtph.2006.09.001
14. U.S. Department of Health and Human Services. (1988). The health consequences of smoking: Nicotine and addiction. A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Center for Health Promotion and Education, Office on Smoking and Health.
15. U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease. A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health.
16. Westman, E. C., Levin, E. D., & Rose, J. E. (1992). Smoking while wearing the nicotine patch: Is smoking satisfying or harmful? Clinical Research, 40, 871A.
17. Zeller, M., Hatsukami, D., & Strategic Dialogue on Tobacco Harm Reduction Group. (2009). The Strategic Dialogue on Tobacco Harm Reduction: A vision and blueprint for action in the US. Tobacco Control, 18, 324-332. doi:10.1136/tc.2008.027318f